University of New South Wales Kirby Institute: Expert Commentary - We Need to Focus on Key Populations to Reduce the Burden of Hepatitis C by 2030
August 13, 2020
August 13, 2020
SYDNEY, Australia, Aug. 13 -- The University of New South Wales Kirby Institute issued the following news:
While the development of highly curative direct-acting antiviral (DAA) therapy has transformed the treatment of hepatitis C virus (HCV) around the world, a cross-disciplinary approach to prevention and treatment, like that adopted by Australia, is required to meet the World Health Organization's HCV elimination targets by 2030, according to an expert commentary published t . . .
While the development of highly curative direct-acting antiviral (DAA) therapy has transformed the treatment of hepatitis C virus (HCV) around the world, a cross-disciplinary approach to prevention and treatment, like that adopted by Australia, is required to meet the World Health Organization's HCV elimination targets by 2030, according to an expert commentary published t . . .